Latest news
Tenaya’s TN-201 Gene Therapy Shows Hypertrophy Reduction in HCM Patients - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTDrug that treats nonobstructive HCM gains FDA Fast Track designation - Cardiovascular BusinessCardiovascular Business · Fri, 31 Jul 2026 15:56:26 GMTLexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTLexicon's HCM study spans 20 countries; results anticipated Q1 2027 - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT